Trellus Health plc (TRLS) ORD GBP0.0006

Sell:2.10pBuy:2.30p0.30p (12.00%)

Prices delayed by at least 15 minutes
Sell:2.10p
Buy:2.30p
Change:0.30p (12.00%)
Prices delayed by at least 15 minutes
Sell:2.10p
Buy:2.30p
Change:0.30p (12.00%)
Prices delayed by at least 15 minutes

Company Information

About this company

Trellus Health plc is a United Kingdom-based health services company, which is engaged in providing solutions and services for chronic condition management. The Company is focused on chronic costly GI conditions that have high mental health burden, such as inflammatory bowel disease (IBD) which includes the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The Company has one division being the providing resilience-driven care for chronic conditions in the inflammatory bowel disease state. The Company’s Trellus Elevate platform is a connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Trellus Elevate’s personalized health roadmaps include engaging lessons and skill-building techniques designed to empower individuals. The Company’s wholly owned subsidiary is Trellus Health Inc.

Key people

Marla C. Dubinsky
Chief Executive Officer, Executive Director
Joy Bessenger
Chief Financial Officer
Salim Hamir
Company Secretary
Kevin L. Murphy
Non-Executive Independent Director - Chair Designate
Brian T. Griffin
Non-Executive Director
Erik Lium
Non-Executive Director
Mike Salter
Non-Executive Director
Traci Entel
Senior Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    TRLS
  • Location
    United Kingdom
  • Sector
    Technology
  • Industry
    Software & Programming
  • ISIN
    GB00BNNFM402
  • Market cap
    £3.55m
  • Employees
    19
  • Shares in issue
    161.51m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.